| Evelyn J Nakagawa Md Inc | |
|
2800 Benedict Dr San Leandro CA 94577-6840 | |
| (415) 945-1010 | |
| Not Available |
| Full Name | Evelyn J Nakagawa Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 2800 Benedict Dr, San Leandro, California |
| Authorized Official Name and Position | Evelyn J Nakagawa (PRESIDENT) |
| Authorized Official Contact | 4159451010 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Evelyn J Nakagawa Md Inc 14 Tamal Vista Blvd Corte Madera CA 94925-1107 Ph: (415) 233-3604 | Evelyn J Nakagawa Md Inc 2800 Benedict Dr San Leandro CA 94577-6840 Ph: (415) 945-1010 |
| NPI Number | 1003577305 |
|---|---|
| Provider Enumeration Date | 01/07/2022 |
| Last Update Date | 01/07/2022 |
| Medicare PECOS PAC ID | 2466846399 |
|---|---|
| Medicare Enrollment ID | O20220218000896 |
News Archive
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
On Oct. 26 & 27, the surgical team from Rennes University Hospital, led by Dr. Erwan Flecher and Prof. Jean-Philippe Verhoye, completed the first phase of certification training for the SynCardia temporary CardioWest™ Total Artificial Heart in Paris. The team trained exclusively with the new Companion Driver System, which received the CE Mark to power the Total Artificial Heart in Europe on Oct. 13.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003577305 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Evelyn J Nakagawa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1023077294 PECOS PAC ID: 7214090414 Enrollment ID: I20090114000604 |
News Archive
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
On Oct. 26 & 27, the surgical team from Rennes University Hospital, led by Dr. Erwan Flecher and Prof. Jean-Philippe Verhoye, completed the first phase of certification training for the SynCardia temporary CardioWest™ Total Artificial Heart in Paris. The team trained exclusively with the new Companion Driver System, which received the CE Mark to power the Total Artificial Heart in Europe on Oct. 13.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
› Verified 7 days ago
| Provider Name | Edward D Esplin |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1689883308 PECOS PAC ID: 1456424357 Enrollment ID: I20131029000171 |
News Archive
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
On Oct. 26 & 27, the surgical team from Rennes University Hospital, led by Dr. Erwan Flecher and Prof. Jean-Philippe Verhoye, completed the first phase of certification training for the SynCardia temporary CardioWest™ Total Artificial Heart in Paris. The team trained exclusively with the new Companion Driver System, which received the CE Mark to power the Total Artificial Heart in Europe on Oct. 13.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
› Verified 7 days ago
| Provider Name | Juan-david Nino-lopez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386307569 PECOS PAC ID: 0749647659 Enrollment ID: I20230608001681 |
News Archive
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
On Oct. 26 & 27, the surgical team from Rennes University Hospital, led by Dr. Erwan Flecher and Prof. Jean-Philippe Verhoye, completed the first phase of certification training for the SynCardia temporary CardioWest™ Total Artificial Heart in Paris. The team trained exclusively with the new Companion Driver System, which received the CE Mark to power the Total Artificial Heart in Europe on Oct. 13.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
› Verified 7 days ago
News Archive
Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.
On Oct. 26 & 27, the surgical team from Rennes University Hospital, led by Dr. Erwan Flecher and Prof. Jean-Philippe Verhoye, completed the first phase of certification training for the SynCardia temporary CardioWest™ Total Artificial Heart in Paris. The team trained exclusively with the new Companion Driver System, which received the CE Mark to power the Total Artificial Heart in Europe on Oct. 13.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Researchers at MIT, Draper, and Brigham and Women's Hospital have designed an ingestible capsule that can be controlled using Bluetooth wireless technology. The capsule, which can be customized to deliver drugs, sense environmental conditions, or both, can reside in the stomach for at least a month, transmitting information and responding to instructions from a user's smartphone.
› Verified 7 days ago
Daniel C Anderson Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 13847 E 14th St Ste 100, San Leandro, CA 94578 Phone: 510-352-6910 Fax: 510-352-4216 | |
California Cardiovascular Consultants Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1532 150th Ave, San Leandro, CA 94578 Phone: 510-351-6363 Fax: 510-278-3757 | |
Alameda County Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15400 Foothill Blvd, San Leandro, CA 94578 Phone: 510-346-1468 Fax: 510-894-7286 | |
San Leandro Mobile Van Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 16110 E 14th St, San Leandro, CA 94578 Phone: 510-471-5880 | |
Dariush Zandi Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 13851 E 14th St Ste 102, San Leandro, CA 94578 Phone: 510-351-2100 Fax: 510-357-3389 | |
Davis Street Primary Care Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3081 Tegarden, San Leandro, CA 94577 Phone: 510-347-4620 Fax: 510-486-4486 |